Skip to content
Open access

An Observational and Comparative Study of Cardiovascular Drug: Chlorthalidone and Hydrochlorothiazide the First Line Drug Therapy of Hypertension

Aug 2026 · Journal of Drug Delivery and Therapeutics · 0 citations · 10 references

TL;DR

The present study revealed that the hypertension patients have poor quality of life and it is very important to improve their quality of life so that the patients can enjoy their day-to-day life.

Abstract

Background: Hypertension is when the pressure in blood pressure vessels is too high. The heart has to work harder to pump blood. Hypertension also known as silent killer. There are 2 types of hypertensions each has a different cause. It causes complications such as heart attack or stroke heart failure, kidney problems, metabolic syndrome, etc. The risk of hypertension increases with age. Smoking and alcohol consumption also raises blood pressure. Objective: The present investigation to observe and compare cardiovascular drug chlorthalidone versus hydrochlorothiazide the first line drug therapy of hypertension. Methodologies: - The present observational study was conducted on 133 hypertension patients. This study was evaluated for the comparative study of two prescribed drugs that is, hydrochlorothiazide and chlorthalidone on hypertension patient the data was collected using suitable design data collection form. Patients having comorbidities conditions were excluded. Results: Among 133 patients, 26% of total study population were females and 74% of total population were males. Majority of the patients were in the age group of 45-54 years accounting 33.83% of total study population and total 24.06% were alcoholic and chronic smoker. In this study we were included the patient on drug therapy of hydrochlorothiazide and chlorthalidone in which 61% were prescribed for hydrochlorothiazide treatment and 39% to a prescribed for chlorthalidone treatment and as per the data collected chlorthalidone lasts longer in the body than hydrochlorothiazide and it lasts up to 36 hours in the body. Chlorthalidone is 1 to 2 times as potent as hydrochlorothiazide but the quality of life of hydrochlorothiazide is better than chlorthalidone accounting with 61% Conclusion: The present study revealed that the hypertension patients have poor quality of life and it is very important to improve their quality of life so that the patients can enjoy their day-to-day life. Experts prefer chlorthalidone and hydrochlorothiazide both works well but hydrochlorothiazide prescribe more often. Keywords: Hypertension, blood pressure, chlorthalidone and hydrochlorothiazide

Read PDF

Similar papers

Open access Aug 2026

A comparative analysis on safety and efficacy of telmisartan and ramipril in treatment of hypertension in a tertiary care hospital

Background: Hypertension is a major global health challenge and an important risk factor for cardiovascular disease. Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are commonly used first-line antihypertensive agents. This study evaluated the safety and efficacy of telmisartan...

Wajid Gulzar, Mudasir Manzoor Dar, Amritpal Singh et al. · 0 citations
Open access Jul 2026

The Impact of Polypharmacy on Blood Pressure Achievement in Hypertensive Patients with Complications

No significant relationship was identified between polypharmacy and blood pressure target achievement among hypertensive patients, and regular evaluation of polypharmacy remains essential to minimize drug interactions and optimize therapeutic outcomes in hypertensive patients.

Elly Megasari, Syarofina Diniati, Arifani Siswidiasari et al. · 0 citations
Open access Jul 2026

Assessment of Drug Utilization Pattern in Patients with Hypertension

Prescribing practices in patients with hypertension in India were largely rational with good adherence to guidelines, however, improvement in patient education and optimization of therapy is needed.

Sachida Nand Sachit, Kumar Devashish · 0 citations
Open access Jul 2026

The effect of antihypertensive therapy on the levels of biomarkers of systemic inflammation in patients with hypertension

In patients with hypertension, combined treatment with perindopril and amlodipine showed a decrease in the concentrations of interleukin-1β, interleukin-8, cystatin C, and angiotensin II over the course of a year.

N. Yasiukaits, O. Pavlova, T. Denisevich et al. · 0 citations
Open access Jul 2026

Prevalence and Risk Factors of Resistant Hypertension Among Patients Attending General Medicine OPD: A Cross-Sectional Observational Study

Resistant hypertension is a serious condition that impacts close to a fifth of patients with hypertension and it is closely linked with metabolic abnormality, sleeping disorders, and poor adherence to medication, so early diagnosis and specific actions are required.

Nilashish Dey · 0 citations
Open access Aug 2026

Blood Pressure Control Following Fixed-dose Combination Antihypertensive Therapy in a Private Nigerian Cardiology Setting: A Retrospective Descriptive Study

Antihypertensive therapy, particularly commonly used combination regimens, was associated with significant reductions in blood pressure and improved control rates across follow-up visits in this private Nigerian clinical setting.

Tosin Majekodunmi, M. C. Nnamdi, E. Ezeh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.